https://old.journalforclinicalstudies.com/astrazenecas-farxiga-pads-its-case-for-new-heart-helping-approval/ 2019-08-22T10:08:28+00:00 https://old.journalforclinicalstudies.com/astrazenecas-imfinzi-tremelimumab-duo-flops-another-late-stage-lung-cancer-trial/ 2019-08-22T10:01:28+00:00 https://old.journalforclinicalstudies.com/medicines-co-awaits-its-date-with-destiny/ 2019-08-22T09:28:30+00:00 https://old.journalforclinicalstudies.com/regeneron-gets-cholesterol-drug-win-where-praluent-wont-go/ 2019-08-22T09:00:15+00:00 https://old.journalforclinicalstudies.com/roche-cancer-drug-the-3rd-approved-for-pan-tumor-use/ 2019-08-22T08:56:53+00:00 https://old.journalforclinicalstudies.com/study-finds-lack-of-racial-diversity-in-cancer-drug-clinical-trials/ 2019-08-22T08:39:06+00:00 https://old.journalforclinicalstudies.com/regenerons-eylea-snags-prefilled-syringe-approval-as-novartis-rival-looms/ 2019-08-15T10:14:41+00:00 https://old.journalforclinicalstudies.com/new-drug-shows-encouraging-survival-in-pancreatic-cancer/ 2019-08-15T09:42:50+00:00 https://old.journalforclinicalstudies.com/az-mercks-latest-lynparza-combo-win-could-widen-its-ovarian-cancer-reach/ 2019-08-15T09:40:03+00:00 https://old.journalforclinicalstudies.com/study-success-strengthens-case-for-lynparza-in-ovarian-cancer/ 2019-08-15T09:29:14+00:00 https://old.journalforclinicalstudies.com/deciphera-success-sets-up-2-horse-race-in-gastrointestinal-cancer/ 2019-08-15T09:25:10+00:00 https://old.journalforclinicalstudies.com/as-ebola-outbreak-rages-researchers-find-promise-in-regeneron-drug/ 2019-08-15T09:21:19+00:00 https://old.journalforclinicalstudies.com/onevision-creating-a-global-standardized-laboratory-network-for-sgs-life-sciences/ 2019-08-14T13:51:03+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/08/OneVision-emailbanner-1-1.png https://old.journalforclinicalstudies.com/novartis-ceo-we-did-the-best-we-could-in-zolgensma-data-manipulation-probe/ 2019-08-08T09:33:37+00:00 https://old.journalforclinicalstudies.com/fda-ready-to-crack-down-as-novartis-reveals-manipulated-zolgensma-data/ 2019-08-08T09:23:00+00:00 https://old.journalforclinicalstudies.com/merck-and-az-pile-on-more-positive-lynparza-data-in-bid-to-break-into-prostate-cancer/ 2019-08-08T09:11:12+00:00 https://old.journalforclinicalstudies.com/roche-trial-win-for-tecentriq-leaves-questions-unanswered/ 2019-08-08T09:05:49+00:00 https://old.journalforclinicalstudies.com/regulators-gilead-at-odds-over-hiv-drugs-use-in-women/ 2019-08-08T09:03:39+00:00 https://old.journalforclinicalstudies.com/fda-approves-first-therapy-for-rare-joint-tumor/ 2019-08-08T08:41:57+00:00 https://old.journalforclinicalstudies.com/experts-predict-chat-bots-and-virtualisation-as-on-trend/ 2019-08-06T13:32:51+00:00 https://old.journalforclinicalstudies.com/bayer-bristol-myers-squibb-and-ono-pharmaceutical-enter-into-a-clinical-collaboration-agreement/ 2019-08-01T09:49:35+00:00 https://old.journalforclinicalstudies.com/novartis-kisqali-sharpens-survival-edge-with-second-ph3-win/ 2019-08-01T09:06:30+00:00 https://old.journalforclinicalstudies.com/chasing-pfizer-and-jj-bayers-nubeqa-nabs-fast-fda-nod-in-prostate-cancer/ 2019-08-01T08:48:22+00:00 https://old.journalforclinicalstudies.com/jj-advances-ms-drug-candidate-toward-us-eu-markets/ 2019-08-01T08:45:35+00:00 https://old.journalforclinicalstudies.com/novartis-heart-drug-misses-on-potentially-billion-dollar-market/ 2019-08-01T08:39:03+00:00 https://old.journalforclinicalstudies.com/lilly-cancer-push-boosted-by-survival-benefit-to-key-drug/ 2019-08-01T08:35:13+00:00 https://old.journalforclinicalstudies.com/kazia-to-use-drug-with-radiotherapy-for-brain-cancer-treatment/ 2019-07-25T08:44:11+00:00 https://old.journalforclinicalstudies.com/find-ilbs-calls-for-joint-action-against-hepatitis/ 2019-07-25T08:40:38+00:00 https://old.journalforclinicalstudies.com/laurus-labs-launches-pregabalin-capsules-in-us-market/ 2019-07-25T08:34:29+00:00 https://old.journalforclinicalstudies.com/akebia-submits-new-application-for-anemia-drug-in-japan/ 2019-07-25T08:25:05+00:00 https://old.journalforclinicalstudies.com/fda-approves-arthritis-drug-by-samsung-bioepis/ 2019-07-25T08:22:34+00:00 https://old.journalforclinicalstudies.com/sanofi-signs-exclusive-deal-for-otc-rights-to-tamiflu/ 2019-07-25T08:19:35+00:00 https://old.journalforclinicalstudies.com/trivitron-healthcare-launches-fully-automated-clinical-chemistry-analyzer/ 2019-07-25T08:15:43+00:00 https://old.journalforclinicalstudies.com/uk-first-as-london-hospital-takes-part-in-new-international-clinical-trial-for-brain-cancer/ 2019-07-15T10:45:08+00:00 https://old.journalforclinicalstudies.com/despite-late-stage-win-investors-not-sold-on-global-blood-sickle-cell-drug/ 2019-07-15T10:00:07+00:00 https://old.journalforclinicalstudies.com/bowel-cancer-3-drug-combo-may-offer-alternative-to-chemo/ 2019-07-15T09:52:47+00:00 https://old.journalforclinicalstudies.com/new-drug-relieves-acute-migraine-in-clinical-trial/ 2019-07-15T09:09:15+00:00 https://old.journalforclinicalstudies.com/amgens-kras-success-has-other-drugmakers-eager-to-follow/ 2019-07-15T09:03:53+00:00 https://old.journalforclinicalstudies.com/healthy-lifestyle-may-offset-genetic-risk-of-dementia/ 2019-07-15T08:30:43+00:00 https://old.journalforclinicalstudies.com/weak-data-spur-amgen-novartis-to-can-pivotal-alzheimers-test/ 2019-07-12T15:45:30+00:00 https://old.journalforclinicalstudies.com/roche-touts-torrent-of-hemlibra-data-amid-hemophilia-gene-therapy-deal-delays/ 2019-07-11T09:51:41+00:00 https://old.journalforclinicalstudies.com/alnylams-onpattro-back-in-the-game-against-ionis-thanks-to-nice-u-turn/ 2019-07-11T09:46:04+00:00 https://old.journalforclinicalstudies.com/score-good-pharma-ranking-finds-uptick-in-new-drug-data-sharing-and-clinical-trial-transparency/ 2019-07-11T09:16:57+00:00 https://old.journalforclinicalstudies.com/new-gsk-data-raises-threat-to-gileads-star-hiv-drug/ 2019-07-11T09:09:40+00:00 https://old.journalforclinicalstudies.com/intra-cellulars-depression-drug-goes-1-for-2-in-phase-3-studies/ 2019-07-11T09:06:17+00:00 https://old.journalforclinicalstudies.com/arrays-colorectal-cancer-data-shows-why-pfizer-splashed-out-11b-for-the-biotech/ 2019-07-11T09:02:26+00:00 https://old.journalforclinicalstudies.com/amarin-plots-salesforce-hiring-binge-to-prep-for-new-vascepa-approval/ 2019-07-04T10:06:21+00:00 https://old.journalforclinicalstudies.com/sanofi-regenerons-libtayo-hits-hot-streak-with-eu-green-light-nice-backing/ 2019-07-04T10:01:24+00:00 https://old.journalforclinicalstudies.com/gilead-firms-up-path-to-market-for-key-arthritis-drug/ 2019-07-04T09:55:26+00:00 https://old.journalforclinicalstudies.com/new-study-showing-drug-prolongs-life-for-patients-with-ovarian-cancer/ 2019-07-04T09:47:30+00:00 https://old.journalforclinicalstudies.com/fda-approves-new-treatment-for-refractory-multiple-myeloma/ 2019-07-04T09:45:08+00:00 https://old.journalforclinicalstudies.com/fda-officials-see-missed-opportunity-with-patient-outcomes-in-clinical-trials/ 2019-07-04T09:43:31+00:00 https://old.journalforclinicalstudies.com/parexel-strengthens-risk-based-monitoring-offering-with-cluepoints-new-advanced-statistical-capabilities/ 2019-06-28T13:58:38+00:00 https://old.journalforclinicalstudies.com/fda-fast-tracks-bi-lillys-jardiance-in-chronic-heart-failure/ 2019-06-27T10:04:31+00:00 https://old.journalforclinicalstudies.com/minervas-sleep-drug-bests-ambien-placebo-in-dose-finding-study/ 2019-06-27T09:18:05+00:00 https://old.journalforclinicalstudies.com/beating-keytruda-a-big-task-exelixis-and-roche-find/ 2019-06-27T09:10:40+00:00 https://old.journalforclinicalstudies.com/regeneron-sanofi-antibody-works-in-asthma-but-not-as-well-as-dupixent/ 2019-06-27T09:09:13+00:00 https://old.journalforclinicalstudies.com/regorafenib-to-be-tested-in-brain-cancer-patients-in-multi-arm-cooperation-trial/ 2019-06-27T09:06:35+00:00 https://old.journalforclinicalstudies.com/fda-lifts-hold-on-abbvie-multiple-myeloma-study/ 2019-06-27T09:02:03+00:00 https://old.journalforclinicalstudies.com/immusant-cans-phase-2-celiac-trial-after-interim-efficacy-review/ 2019-06-27T08:54:05+00:00 https://old.journalforclinicalstudies.com/japan-the-first-to-approve-roches-personalised-medicine-rozlytrek/ 2019-06-20T08:57:05+00:00 https://old.journalforclinicalstudies.com/agilent-receives-fda-approval-for-companion-diagnostic-assay/ 2019-06-20T08:50:46+00:00 https://old.journalforclinicalstudies.com/who-launches-new-tool-to-handle-amr/ 2019-06-20T08:48:09+00:00 https://old.journalforclinicalstudies.com/varian-completes-acquisition-of-cancer-treatment-services-international/ 2019-06-20T08:43:54+00:00 https://old.journalforclinicalstudies.com/sanofi-and-google-to-develop-healthcare-innovation-lab/ 2019-06-20T08:40:53+00:00 https://old.journalforclinicalstudies.com/new-survey-finds-fragmented-processes-and-system-silos-slowing-clinical-trials/ 2019-06-19T12:23:47+00:00 https://old.journalforclinicalstudies.com/biotechs-dive-deeper-into-targeted-cancer-research-despite-costs/ 2019-06-13T12:13:21+00:00 https://old.journalforclinicalstudies.com/experimental-drug-delays-type-1-diabetes-in-research-first/ 2019-06-13T12:09:46+00:00 https://old.journalforclinicalstudies.com/ada-jjs-struggling-invokana-slashes-heart-kidney-risks-in-latest-trial-win/ 2019-06-13T12:07:45+00:00 https://old.journalforclinicalstudies.com/roche-touts-phase-2-gazyva-data-in-lupus-patients-with-a-potentially-fatal-kidney-complication/ 2019-06-13T09:33:42+00:00 https://old.journalforclinicalstudies.com/nash-trial-miss-halves-cymabays-market-value/ 2019-06-13T09:29:30+00:00 https://old.journalforclinicalstudies.com/look-here-fda-eli-lilly-touts-olumiant-safety-data-for-unapproved-high-dose/ 2019-06-13T09:15:52+00:00 https://old.journalforclinicalstudies.com/phoenix-molecular-designs-and-wuxi-sta-reach-drug-supply-milestone-to-support-phase-i-ib-study-of-pmd-026-for-tnbc/ 2019-06-11T10:09:24+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-announces-further-expansion-in-san-diego-to-maintain-industry-leading-quality-service-and-flexibility/ 2019-06-06T14:23:25+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/06/Canyon-Ridge-III_7911_03Jun2019.jpg https://old.journalforclinicalstudies.com/novartis-kisqali-significantly-extends-life-in-women-with-hr-her2-advanced-breast-cancer-in-monaleesa-7-trial/ 2019-06-06T09:14:09+00:00 https://old.journalforclinicalstudies.com/macrogenics-dives-as-breast-cancer-drug-shows-small-improvement/ 2019-06-06T09:08:51+00:00 https://old.journalforclinicalstudies.com/fda-open-for-business-in-considering-real-world-evidence-sharpless-says/ 2019-06-06T09:06:46+00:00 https://old.journalforclinicalstudies.com/abbvie-unveils-venclexta-data-that-scored-lightning-fast-leukemia-combination-nod/ 2019-06-06T08:58:30+00:00 https://old.journalforclinicalstudies.com/lung-therapeutics-raises-36m-to-trial-pleural-effusion-drug/ 2019-06-06T08:52:28+00:00 https://old.journalforclinicalstudies.com/research-point-global-and-wuxi-cds-to-rebrand-as-wuxi-clinical-a-client-centric-cro-at-dia-2019/ 2019-06-05T15:11:25+00:00 https://old.journalforclinicalstudies.com/amgen-joins-with-community-oncology-networks-for-new-research-collaboration/ 2019-05-30T10:01:19+00:00 https://old.journalforclinicalstudies.com/roches-personalised-medicine-entrectinib-shrank-tumours-harbouring-ntrk-ros1-or-alk-gene-fusions-in-children-and-adolescents/ 2019-05-30T09:55:19+00:00 https://old.journalforclinicalstudies.com/allergan-puts-vraylar-on-blockbuster-track-with-new-bipolar-depression-nod/ 2019-05-30T09:27:43+00:00 https://old.journalforclinicalstudies.com/follow-up-studies-often-lacking-for-cancer-drugs-approved-early/ 2019-05-30T09:22:04+00:00 https://old.journalforclinicalstudies.com/new-data-show-symbicort-reduces-attacks-in-mild-asthma-when-used-as-an-anti-inflammatory-reliever/ 2019-05-30T09:18:57+00:00 https://old.journalforclinicalstudies.com/no-news-is-bad-news-for-tocagen/ 2019-05-30T09:10:25+00:00 https://old.journalforclinicalstudies.com/depression-esketamine-trial-leaves-more-questions-than-answers/ 2019-05-23T09:00:14+00:00 https://old.journalforclinicalstudies.com/biocryst-meets-late-stage-study-goal-but-falls-short-of-competition/ 2019-05-23T08:44:02+00:00 https://old.journalforclinicalstudies.com/long-term-heart-data-reassures-for-medicines-co/ 2019-05-23T08:41:37+00:00 https://old.journalforclinicalstudies.com/arrays-extremely-compelling-new-colon-cancer-data-spark-blockbuster-talk/ 2019-05-23T08:37:16+00:00 https://old.journalforclinicalstudies.com/benralizumab-not-effective-reducing-exacerbations-in-moderate-to-very-severe-copd/ 2019-05-23T08:32:17+00:00 https://old.journalforclinicalstudies.com/lilly-drug-scores-in-phase-2-crohns-study/ 2019-05-23T08:29:20+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-announces-organization-updates/ 2019-05-20T13:39:06+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/05/T_Roberts.jpg https://old.journalforclinicalstudies.com/wp-content/uploads/2019/05/T_Evans.jpg https://old.journalforclinicalstudies.com/wp-content/uploads/2019/05/J_Schroeder.jpg https://old.journalforclinicalstudies.com/wp-content/uploads/2019/05/S_Ritchie.jpg https://old.journalforclinicalstudies.com/astrazeneca-blood-cancer-drug-hits-study-goal-early/ 2019-05-16T08:57:08+00:00 https://old.journalforclinicalstudies.com/bristol-myers-opdivo-fails-in-phase-3-glioblastoma-test/ 2019-05-16T08:48:53+00:00 https://old.journalforclinicalstudies.com/myovant-reports-a-phase-3-success-but-wall-street-isnt-cheered/ 2019-05-16T08:46:42+00:00 https://old.journalforclinicalstudies.com/pfizer-merck-kgaas-latest-bavencio-nod-sets-up-3-way-kidney-cancer-battle/ 2019-05-16T08:42:37+00:00 https://old.journalforclinicalstudies.com/watch-out-dupixent-pfizers-new-jak-inhibitor-could-come-after-your-eczema-market/ 2019-05-16T08:35:26+00:00 https://old.journalforclinicalstudies.com/trastuzumab-deruxtecan-demonstrated-clinically-meaningful-response-in-patients-with-refractory-her2-positive-metastatic-breast-cancer/ 2019-05-16T08:32:08+00:00 https://old.journalforclinicalstudies.com/cytokinetics-astellas-fall-short-in-als-trial-but-spin-a-success-story/ 2019-05-09T10:13:54+00:00 https://old.journalforclinicalstudies.com/epidiolex-sales-beat-wall-streets-bar-as-gw-pharma-reports-trial-success/ 2019-05-09T09:16:27+00:00 https://old.journalforclinicalstudies.com/pathbreaking-ionis-trial-offers-way-forward-in-huntingtons-disease/ 2019-05-09T09:13:05+00:00 https://old.journalforclinicalstudies.com/gsk-chases-trelegy-asthma-nod-with-mixed-phase-3-results/ 2019-05-09T09:08:57+00:00 https://old.journalforclinicalstudies.com/awaiting-fda-nod-novartis-touts-latest-data-on-gene-therapy-zolgensma/ 2019-05-09T09:06:16+00:00 https://old.journalforclinicalstudies.com/roches-breast-cancer-hopes-get-a-boost-from-postsurgery-kadcyla-approval/ 2019-05-09T08:55:59+00:00 https://old.journalforclinicalstudies.com/novartis-presents-first-of-its-kind-algorithm-based-tool-to-help-ms-patients-and-physicians/ 2019-05-09T08:35:10+00:00 https://old.journalforclinicalstudies.com/fda-approves-new-treatments-for-heart-disease-caused-by-a-serious-rare-disease-transthyretin-mediated-amyloidosis/ 2019-05-09T08:32:40+00:00 https://old.journalforclinicalstudies.com/sgs-acquires-chemical-solutions-ltd-usa/ 2019-05-07T15:00:16+00:00 https://old.journalforclinicalstudies.com/expansion-of-central-lab-services-to-china/ 2019-05-07T10:10:37+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/05/MLM-meets-Teddy-Labs-scaled.jpg https://old.journalforclinicalstudies.com/novo-seeks-victoza-label-expansion-with-fresh-pediatric-trial-results/ 2019-05-02T08:45:15+00:00 https://old.journalforclinicalstudies.com/another-late-stage-miss-knocks-gilead-from-its-leading-nash-position/ 2019-05-02T08:42:40+00:00 https://old.journalforclinicalstudies.com/clinical-biomarkers-expected-to-lift-rd-productivity-iqvia/ 2019-05-02T08:40:41+00:00 https://old.journalforclinicalstudies.com/biogens-antisense-als-drug-shows-promise-in-early-clinical-trial/ 2019-05-02T08:37:59+00:00 https://old.journalforclinicalstudies.com/drugs-to-prevent-stroke-and-dementia-show-promise-in-early-trial/ 2019-05-02T08:32:31+00:00 https://old.journalforclinicalstudies.com/comprehensive-tumor-profiling-promises-new-therapeutic-options-for-patients-with-advanced-cancer/ 2019-05-02T08:31:13+00:00 https://old.journalforclinicalstudies.com/pci-clinical-services-to-showcase-expertise-in-phase-i-clinical-trials-in-australia-at-east-coast-us-seminars/ 2019-05-01T08:45:34+00:00 https://old.journalforclinicalstudies.com/sgs-implements-veeva-vault-clinical-trial-management-system-across-its-global-network/ 2019-04-30T14:22:57+00:00 https://old.journalforclinicalstudies.com/clinical-trial-supply-west-coast-conference-2019-pcis-rich-nelson-to-discuss-best-practices-in-the-global-movement-of-scheduled-drug-product/ 2019-04-29T12:36:49+00:00 https://old.journalforclinicalstudies.com/redesigned-car-t-eliminates-dangerous-cytokine-release-syndrome-in-lymphoma-trial/ 2019-04-23T10:28:23+00:00 https://old.journalforclinicalstudies.com/roche-throws-in-the-towel-on-tecentriq-bladder-myeloma-trials/ 2019-04-23T10:23:40+00:00 https://old.journalforclinicalstudies.com/pfizer-posts-positive-data-for-20-strain-pneumococcal-vaccine/ 2019-04-23T10:19:45+00:00 https://old.journalforclinicalstudies.com/clovis-shares-slide-on-rubraca-trial-discontinuation/ 2019-04-23T10:18:23+00:00 https://old.journalforclinicalstudies.com/united-therapeutics-scraps-drug-after-late-stage-miss/ 2019-04-23T10:02:39+00:00 https://old.journalforclinicalstudies.com/pfizer-and-lilly-announce-top-line-results-from-long-term-phase-3-study-of-tanezumab-in-patients-with-osteoarthritis/ 2019-04-23T09:57:17+00:00 https://old.journalforclinicalstudies.com/high-dose-vitamin-d-shows-benefit-in-patients-with-advanced-colorectal-cancer/ 2019-04-18T09:03:43+00:00 https://old.journalforclinicalstudies.com/alnylam-looks-to-next-rnai-approval-but-safety-questions-linger/ 2019-04-18T09:00:20+00:00 https://old.journalforclinicalstudies.com/clovis-throws-in-the-towel-on-solo-rubraca-study-in-bladder-cancer/ 2019-04-18T08:58:24+00:00 https://old.journalforclinicalstudies.com/wave-delays-key-data-readout-for-huntingtons-therapy/ 2019-04-18T08:31:34+00:00 https://old.journalforclinicalstudies.com/almac-group-publishes-comparison-report-on-automated-vs-paper-based-accountability-reconciliation/ 2019-04-15T12:12:46+00:00 https://old.journalforclinicalstudies.com/innovative-medicines-initiative-launches-translational-safety-biomarker-pipeline-project-to-enable-development-and-implementation-of-novel-safety-biomarkers/ 2019-04-15T12:10:46+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/04/TransBioLine-Kick-off-1-scaled.jpg https://old.journalforclinicalstudies.com/reformulated-epileptic-drug-reaches-first-clinical-trial-for-medically-refractory-epilepsy/ 2019-04-08T14:57:00+00:00 https://old.journalforclinicalstudies.com/new-clinical-trials-to-investigate-combination-immunotherapy-for-treating-advanced-cancers/ 2019-04-08T14:53:08+00:00 https://old.journalforclinicalstudies.com/sangamo-hemophilia-a-progress-boosts-shares/ 2019-04-08T14:04:27+00:00 https://old.journalforclinicalstudies.com/united-therapeutics-tosses-out-esuberaprost-after-trial-flop/ 2019-04-08T14:01:00+00:00 https://old.journalforclinicalstudies.com/pfizer-wins-expanded-ibrance-approval-using-real-world-data/ 2019-04-08T13:53:15+00:00 https://old.journalforclinicalstudies.com/no-return-for-the-merrimack/ 2019-04-08T13:51:41+00:00 https://old.journalforclinicalstudies.com/myoderm-executive-leadership-announcement-press-release/ 2019-04-05T09:20:21+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/04/Mike-Cohen-Myoderm-CEO.jpg https://old.journalforclinicalstudies.com/wp-content/uploads/2019/04/James-Lovett-Myoderm-COO.jpg https://old.journalforclinicalstudies.com/allergan-eye-drug-fails-to-impress-on-safety-upping-pressure-ahead-of-key-meeting/ 2019-04-04T08:48:22+00:00 https://old.journalforclinicalstudies.com/dementia-amyloid-pet-scans-can-improve-diagnosis-and-care/ 2019-04-04T08:43:08+00:00 https://old.journalforclinicalstudies.com/early-pancreatic-cancer-data-give-clovis-a-new-path-in-parp-market/ 2019-04-04T08:37:21+00:00 https://old.journalforclinicalstudies.com/astellas-aml-therapy-bests-chemo-in-phase-3-study/ 2019-04-04T08:33:48+00:00 https://old.journalforclinicalstudies.com/selumetinib-granted-us-breakthrough-therapy-designation-in-neurofibromatosis-type-1/ 2019-04-04T08:30:24+00:00 https://old.journalforclinicalstudies.com/clinical-trial-finds-therapy-to-be-well-tolerated-in-patients-with-aggressive-brain-tumour/ 2019-04-04T08:28:09+00:00 https://old.journalforclinicalstudies.com/triphase-accelerator-initiates-phase-1-clinical-trial-of-trph-222-in-b-cell-lymphoma/ 2019-04-01T14:09:04+00:00 https://old.journalforclinicalstudies.com/fda-warns-doctors-myeloma-patients-of-doubled-death-risk-from-abbvie-roches-venclexta/ 2019-03-28T11:53:34+00:00 https://old.journalforclinicalstudies.com/azs-farxiga-nabbed-its-type-1-nod-in-eu-but-after-zynquistas-rebuff-how-will-it-fare-at-fda/ 2019-03-28T11:50:40+00:00 https://old.journalforclinicalstudies.com/parkinsons-study-reveals-how-cancer-drug-reduces-toxic-protein-in-brain/ 2019-03-28T11:18:39+00:00 https://old.journalforclinicalstudies.com/surgery-with-ultrasound-treats-high-blood-pressure-in-trial/ 2019-03-28T11:00:45+00:00 https://old.journalforclinicalstudies.com/aimmunes-peanut-drug-moves-closer-to-european-market/ 2019-03-28T10:51:04+00:00 https://old.journalforclinicalstudies.com/conatus-drug-misses-goal-hitting-nash-stocks/ 2019-03-28T10:46:31+00:00 https://old.journalforclinicalstudies.com/forxiga-approved-in-japan-for-type-1-diabetes/ 2019-03-28T10:41:31+00:00 https://old.journalforclinicalstudies.com/pci-announces-expansion-of-high-potent-tableting-and-powder-modification-capacity/ 2019-03-25T15:31:05+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-appoints-new-chief-financial-officer-svp-serge-dupuis/ 2019-03-25T14:20:39+00:00 https://old.journalforclinicalstudies.com/researchers-report-promising-results-of-potential-reversal-agent/ 2019-03-21T10:38:17+00:00 https://old.journalforclinicalstudies.com/apple-heart-study-early-proof-of-concept-or-a-bit-of-a-gimmick/ 2019-03-21T10:34:36+00:00 https://old.journalforclinicalstudies.com/lillys-cyramza-comes-up-positive-in-first-line-lung-cancer-trial/ 2019-03-21T10:32:46+00:00 https://old.journalforclinicalstudies.com/pfizer-merck-kgaa-scrap-yet-another-bavencio-ovarian-cancer-trial/ 2019-03-21T10:30:45+00:00 https://old.journalforclinicalstudies.com/tecentriq-assumes-pole-position-with-fda-approval-but-keytruda-looms-in-triple-negative-breast-cancer-says-globaldata/ 2019-03-21T09:51:16+00:00 https://old.journalforclinicalstudies.com/praluent-alirocumab-now-approved-in-european-union-to-reduce-the-risk-of-cardiovascular-events-in-patients-with-established-cardiovascular-disease/ 2019-03-21T09:48:37+00:00 https://old.journalforclinicalstudies.com/ardelyxs-tenapanor-may-be-answer-to-growing-demand-for-novel-ckd-mbd-treatments-says-globaldata/ 2019-03-21T09:46:19+00:00 https://old.journalforclinicalstudies.com/crf-bracket-supports-remote-consenting-for-virtual-clinical-studies-with-latest-release-of-its-integrated-econsent-solution/ 2019-03-21T09:44:04+00:00 https://old.journalforclinicalstudies.com/the-flow-diversion-stent-market-is-growing-at-a-cagr-of-approximately-2-says-globaldata/ 2019-03-21T09:42:37+00:00 https://old.journalforclinicalstudies.com/phase-iii-failure-for-pollinex-quattro-birch-puts-allergy-therapeutics-in-a-precarious-position-for-long-awaited-us-expansion-says-globaldata/ 2019-03-21T09:39:59+00:00 https://old.journalforclinicalstudies.com/sotios-dcvac-ovca-significantly-improves-survival-in-patients-with-recurrent-ovarian-cancer/ 2019-03-21T09:39:03+00:00 https://old.journalforclinicalstudies.com/life-sciences-companies-adopt-veeva-nitro-to-eliminate-the-burden-of-custom-data-warehouse-development-and-maintenance/ 2019-03-19T16:13:45+00:00 https://old.journalforclinicalstudies.com/clinical-trial-supply-new-england-conference-2019-pcis-jeremy-osborne-to-share-his-expertise-on-accelerating-into-early-clinical-trials-with-speed-and-flexibility/ 2019-03-15T15:14:38+00:00 https://old.journalforclinicalstudies.com/fda-green-lights-two-therapies-while-late-stage-successes-set-stage-for-potential-approvals/ 2019-03-13T11:21:53+00:00 https://old.journalforclinicalstudies.com/takedas-entyvio-beats-abbvies-humira-in-head-to-head-uc-study/ 2019-03-13T11:01:00+00:00 https://old.journalforclinicalstudies.com/new-drug-may-stop-sepsis-from-reaching-major-organs/ 2019-03-13T10:59:45+00:00 https://old.journalforclinicalstudies.com/new-brain-stimulation-therapy-is-effective-against-depression/ 2019-03-13T10:57:59+00:00 https://old.journalforclinicalstudies.com/ozempic-superior-in-lowering-blood-sugar-and-weight-vs-placebo-both-in-combination-with-sglt-2-inhibitors/ 2019-03-13T10:51:33+00:00 https://old.journalforclinicalstudies.com/szpital-specjalistyczny-w-brzozowie-poland-joins-the-global-hospital-network-on-clinerions-patient-network-explorer-platform/ 2019-03-13T10:31:19+00:00 https://old.journalforclinicalstudies.com/envigo-launches-pathway-an-optimized-safety-assessment-solution-to-enable-first-in-human-clinical-trials/ 2019-03-13T10:19:16+00:00 https://old.journalforclinicalstudies.com/erytech-presents-findings-at-european-red-cell-research-society-meeting/ 2019-03-13T10:15:30+00:00 https://old.journalforclinicalstudies.com/aldevron-releases-gmp-grade-spyfi-cas9-nuclease/ 2019-03-13T10:12:46+00:00 https://old.journalforclinicalstudies.com/ecco-2019-entyvio-set-to-be-most-dominant-drug-in-the-uc-landscape-following-varsity-trial-says-globaldata/ 2019-03-13T09:54:26+00:00 https://old.journalforclinicalstudies.com/successful-phase-2-clinical-trial-results-with-novel-influenza-vaccine-validate-sgss-h3n2-challenge-agent-a-belgium/ 2019-03-13T09:52:47+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-announces-appointment-of-lisa-spence-as-director-of-clinical-supply-chain-international-region/ 2019-03-12T14:43:46+00:00 https://old.journalforclinicalstudies.com/biogen-launches-cleo-application-to-inform-and-support-anyone-living-with-multiple-sclerosis/ 2019-03-11T15:28:02+00:00 https://old.journalforclinicalstudies.com/worldwide-clinical-trials-and-deep-lens-enter-strategic-alliance-to-accelerate-recruitment-and-development-timelines-for-oncology-trials/ 2019-03-11T13:25:52+00:00 https://old.journalforclinicalstudies.com/crf-bracket-welcomes-susie-robinson-as-chief-people-officer/ 2019-03-08T11:13:07+00:00 https://old.journalforclinicalstudies.com/new-treatment-under-trial-could-restore-brain-cells-in-parkinsons/ 2019-03-07T10:21:17+00:00 https://old.journalforclinicalstudies.com/could-medical-marijuana-help-grandma-and-grandpa-with-their-ailments/ 2019-03-07T10:16:29+00:00 https://old.journalforclinicalstudies.com/second-vertex-triple-combo-succeeds-in-cystic-fibrosis-setting-up-crucial-choice/ 2019-03-07T10:13:47+00:00 https://old.journalforclinicalstudies.com/alnylams-givosiran-clears-phase-3-test-in-second-rnai-win/ 2019-03-07T10:12:01+00:00 https://old.journalforclinicalstudies.com/chmp-recommends-zynquistatm-sotagliflozin-for-the-treatment-of-adults-with-type-1-diabetes/ 2019-03-07T10:05:01+00:00 https://old.journalforclinicalstudies.com/chmp-recommends-approval-of-dupixent-dupilumab-for-asthma-indication/ 2019-03-07T09:53:57+00:00 https://old.journalforclinicalstudies.com/novavaxs-rsv-vaccine-fails-second-phase-iii-trial-further-shrinking-its-pathways-to-success-says-globaldata/ 2019-03-07T09:48:47+00:00 https://old.journalforclinicalstudies.com/the-university-of-debrecen-brings-hungarian-patients-in-to-clinerions-patient-network-explorer/ 2019-03-07T09:46:35+00:00 https://old.journalforclinicalstudies.com/nanobiotix-receives-e14-million-through-the-second-tranche-disbursement-of-financing-from-the-european-investment-bank/ 2019-03-07T09:44:49+00:00 https://old.journalforclinicalstudies.com/nightstar-acquisition-will-catapult-biogen-in-global-ophthalmology-market-says-globaldata/ 2019-03-07T09:42:15+00:00 https://old.journalforclinicalstudies.com/wuxi-sta-and-ark-biosciences-sign-cmc-development-and-manufacturing-agreement/ 2019-03-07T09:40:48+00:00 https://old.journalforclinicalstudies.com/diabetes-telemedicine-and-data-science-can-improve-patient-care/ 2019-03-01T13:53:38+00:00 https://old.journalforclinicalstudies.com/crf-bracket-grows-more-in-first-quarter-together-than-either-company-achieved-alone-in-2018/ 2019-02-28T13:32:20+00:00 https://old.journalforclinicalstudies.com/astrazenecas-parp-drug-succeeds-in-pancreatic-cancer-study/ 2019-02-28T10:19:06+00:00 https://old.journalforclinicalstudies.com/novartis-moves-forward-on-cv-drug-paying-150m-to-ionis-akcea/ 2019-02-28T10:17:21+00:00 https://old.journalforclinicalstudies.com/brilintas-phase-iii-themis-trial-met-primary-endpoint-in-%e2%80%a8patients-with-established-coronary-artery-disease-and-type-2-diabetes/ 2019-02-28T10:11:01+00:00 https://old.journalforclinicalstudies.com/new-treatment-offers-potentially-promising-results-for-the-possibility-of-slowing-stopping-or-even-reversing-parkinsons-disease/ 2019-02-28T10:09:27+00:00 https://old.journalforclinicalstudies.com/long-term-benefits-from-intensive-therapy-in-early-stages-of-ms/ 2019-02-28T10:07:00+00:00 https://old.journalforclinicalstudies.com/mercks-infant-pneumococcal-vaccine-could-threaten-pfizers-longstanding-market-dominance-says-globaldata/ 2019-02-28T10:03:11+00:00